Abstract
A balance between proliferation, differentiation, migration and death of cells is critical for the normal development of an organism. Perturbations of this balance can contribute to cancer development. The p21-activated serine/threonine kinases (Paks) play an important role in a variety of cellular functions including cell morphogenesis, motility, survival, angiogenesis, and mitosis. Paks were initially identified as an effector molecules of RHO GTPases; however, recent evidence that they can be activated in both GTPase-dependent and -independent manners expands our understanding of their physiologic functions. Paks play an important role in growth factor signaling, leading to cytoskeletal reorganization that subsequently influences growth factor-mediated cell migration and metastasis functions. Recent findings that Paks play a role in mitosis, nuclear receptor-signaling and deregulation of Pak in cancer cells suggest that these kinases play an important role in both normal development and cancer progression. In this review, we summarize the results of recent advances into the role of Paks in tumorigenesis and metastasis.
Similar content being viewed by others
References
Hall A: Rho GTPases and the actin cytoskeleton. Science 279: 509–514, 1998
Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A: The small GTP-binding protein Rac regulates growth factor-induced membrane ruffling. Cell 70: 401–410, 1992
Lauffenburger DA, Horwitz AF: Cell migration: A physically integrated molecular process. Cell 84: 359–369, 1996
Kozma R, Ahmed S, Best A, Lim L: The GTPase-activating protein n-chimaerin cooperates with Rac1 and Cdc42Hs to induce the formation of lamellipodia and filopodia. Mol Cell Biol 16: 5069–5080, 1996
Sells MA, Boyd JT, Chernoff J: p21-activated kinase 1 (Pak1) regulates cell motility in mammalian fibroblasts. J Cell Biol 145: 837–849, 1999
Manser E, Leung T, Salihuddin H, Zhao ZS, Lim L: A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 367: 40–46, 1994
Bagrodia S, Cerione RA: Pak to the future. Trends Cell Biol 9: 350–355, 1999
Jaffer ZM, Chernoff J: p21-activated kinases: Three more join the Pak. Int J Biochem Cell Biol 34: 713–717, 2002
Kumar R, Vadlamudi RK: Emerging functions of p21-activated kinases in human cancer cells. J Cell Physiol 193: 133–144, 2002
Adam L, Vadlamudi R, Kondapaka SB, Chernoff J, Mendelsohn J, Kumar R: Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase. J Biol Chem 273: 28238–28246, 1998
Pandey A, Dan I, Kristiansen TZ, Watanabe NM, Voldby J, Kajikawa E, Khosravi F, Blagoev B, Mann M: Cloning and characterization of PAK5, a novel member of mammalian p21-activated kinase-II subfamily that is predominantly expressed in brain. Oncogene 21: 3939–3948, 2002
Dan C, Nath N, Liberto M, Minden A: PAK5, a new brain-specific kinase, promotes neurite outgrowth in N1E-115 cells. Mol Cell Biol 22: 567–577, 2002
Abo A, Qu J, Cammarano MS, Dan C, Fritsch A, Baud V, Belisle B, Minden A: PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia. EMBO J 17: 6527–6540, 1998
Lee SR, Ramos SM, Ko A, Masiello D, Swanson KD, Lu ML, Balk SP: AR and ER interaction with a p21-activated kinase (PAK6). Mol Endocrinol 16: 85–99, 2002
Royal I, Lamarche V, Lamorte L, Kaibuchi K, Park M: Activation of cdc42, rac, PAK, and rho-kinase in response to hepatocyte growth factor differentially regulates epithelial cell colony spreading and dissociation. Mol Biol Cell 11: 1709–1725, 2000
He H, Levitzki A, Zhu HJ, Walker F, Burgess A, Maruta H: Platelet-derived growth factor requires epidermal growth factor receptor to activate p21-activated kinase family kinases. J Biol Chem 276: 26741–26744, 2001
Bokoch GM, Wang Y, Bohl BP, Sells MA, Quilliam LA, Knaus UG: Interaction of the Nck adapter protein with p21-activated kinase (PAK1). J Biol Chem 271: 25746–25749, 1996
Zhao ZS, Manser E, Loo TH, Lim L: Coupling of PAK-interacting exchange factor PIX to GIT1 promotes focal complex disassembly. Mol Cell Biol 20: 6354–6363, 2000
Papakonstanti EA, Stournaras C: Association of PI-3 Kinase with PAK1 Leads to Actin Phosphorylation and Cytoskeletal Reorganization. Mol Biol Cell 13: 2946–2962, 2002
Bokoch GM, Reilly AM, Daniels RH, King CC, Olivera A, Spiegel S, Knaus UG: A GTPase-independent mechanism of p21-activated kinase activation. Regulation by sphingosine and other biologically active lipids. J Biol Chem 273: 8137–8144, 1998
King CC, Gardiner EM, Zenke FT, Bohl BP, Newton AC, Hemmings BA, Bokoch GM: p21-activated kinase (Pak1) is phosphorylated and activated by 3-phosphoinositidedependent kinase-1 (PDK1). J Biol Chem 275: 41201–41209, 2000
Vadlamudi RK, Li F, Adam L, Nguyen D, Ohta Y, Stossel TP, Kumar R: Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1. Nat Cell Biol 4: 681–690, 2002
Lian JP, Crossley L, Zhan Q, Huang R, Coffer P, Toker A, Robinson D, Badwey JA: Antagonists of calcium fluxes and calmodulin block activation of the p21-activated protein kinases in neutrophils. J Immunol 166: 2643–2650, 2001
Sanders LC, Matsumura F, Bokoch GM, de L: Inhibition of myosin light chain kinase by p21-activated kinase. Science 283: 2083–2085, 1999
Chew TL, Masaracchia RA, Goeckeler ZM, Wysolmerski RB: Phosphorylation of non-muscle myosin II regulatory light chain by p21-activated kinase (gamma-PAK). J Muscle Res Cell Motil 19: 839–854, 1998
Zeng Q, Lagunoff D, Masaracchia R, Goeckeler Z, Cote G, Wysolmerski R: Endothelial cell retraction is induced by PAK2 monophosphorylation of myosin II. J Cell Sci 113(Pt 3): 471–482, 2000
Kiosses WB, Daniels RH, Otey C, Bokoch GM, Schwartz MA: A role for p21-activated kinase in endothelial cell migration. J Cell Biol 147: 831–844, 1999
Goeckeler ZM, Masaracchia RA, Zeng Q, Chew TL, Gallagher P, Wysolmerski RB: Phosphorylation of myosin light chain kinase by p21-activated kinase PAK2. J Biol Chem 275: 18366–18374, 2000
Dharmawardhane S, Sanders LC, Martin SS, Daniels RH, Bokoch GM: Localization of p21-activated kinase 1 (PAK1) to pinocytic vesicles and cortical actin structures in stimulated cells. J Cell Biol 138: 1265–1278, 1997
Edwards DC, Sanders LC, Bokoch GM, Gill GN: Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signaling to actin cytoskeletal dynamics. Nat Cell Biol 1: 253–259, 1999
Vadlamudi RK, Adam L, Wang RA, Mandal M, Nguyen D, Sahin A, Chernoff J, Hung MC, Kumar R: Regulatable expression of p21-activated kinase-1 promotes anchorageindependent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells. J Biol Chem 275: 36238–36244, 2000
Frost JA, KhokhlatchevA, Stippec S, White MA, Cobb MH: Differential effects of PAK1-activating mutations reveal activity-dependent and-independent effects on cytoskeletal regulation. J Biol Chem 273: 28191–28198, 1998
Manser E, Huang HY, Loo TH, Chen XQ, Dong JM, Leung T, Lim L: Expression of constitutively active alpha-PAK reveals effects of the kinase on actin and focal complexes. Mol Cell Biol 17: 1129–1143, 1997
Ohtakara K, Inada H, Goto H, Taki W, Manser E, Lim L, Izawa I, Inagaki M: p21-activated kinase PAK phosphorylates desmin at sites different from those for Rhoassociated kinase. Biochem Biophys Res Commun 272: 712–716, 2000
Goto H, Tanabe K, Manser E, Lim L, Yasui Y, Inagaki M: Phosphorylation and reorganization of vimentin by p21-activated kinase (Pak). Genes Cells 7: 91–97, 2002
Daub H, Gevaert K, Vandekerckhove J, Sobel A, Hall A: Rac/Cdc42 and p65PAK regulate the microtubule-destabilizing protein stathmin through phosphorylation at serine 16. J Biol Chem 276: 1677–1680, 2001
Foster DB, Shen LH, Kelly J, Thibault P, Van E, Mak AS: Phosphorylation of caldesmon by p21-activated kinase. Implications for the Ca(2+) sensitivity of smooth muscle contraction. J Biol Chem 275: 1959–1965, 2000
Cau J, Faure S, Comps M, Delsert C, Morin N: A novel p21-activated kinase binds the actin and microtubule networks and induces microtubule stabilization. J Cell Biol 155: 1029–1042, 2001
Zhang S, Han J, Sells MA, Chernoff J, Knaus UG, Ulevitch RJ, Bokoch GM: Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J Biol Chem 270: 23934–23936, 1995
Frost JA, Xu S, Hutchison MR, Marcus S, Cobb MH: Actions of Rho family small G proteins and p21-activated protein kinases on mitogen-activated protein kinase family members. Mol Cell Biol 16: 3707–3713, 1996
Frost JA, Swantek JL, Stippec S, Yin MJ, Gaynor R, Cobb MH: Stimulation of NFkappa B activity by multiple signaling pathways requires PAK1. J Biol Chem 275: 19693–19699, 2000
Frost JA, Steen H, Shapiro P, Lewis T, Ahn N, Shaw PE, Cobb MH: Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins. EMBO J 16: 6426–6438, 1997
Chaudhary A, King WG, Mattaliano MD, Frost JA, Diaz B, Morrison DK, Cobb MH, Marshall MS, Brugge JS: Phosphatidylinositol 3-kinase regulates Raf1 through Pak phosphorylation of serine 338. Curr Biol 10: 551–554, 2000
Chiloeches A, Mason CS, Marais R: S338 phosphorylation of Raf-1 is independent of phosphatidylinositol 3-kinase and Pak3. Mol Cell Biol 21: 2423–2434, 2001
Howe AK, Juliano RL: Regulation of anchorage-dependent signal transduction by protein kinase A and p21-activated kinase. Nat Cell Biol 2: 593–600, 2000
Callow MG, Clairvoyant F, Zhu S, Schryver B, Whyte DB, Bischoff JR, Jallal B, Smeal T: Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines. J Biol Chem 277: 550–558, 2002
Sun H, King AJ, Diaz HB, Marshall MS: Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak. Curr Biol 10: 281–284, 2000
Schurmann A, Mooney AF, Sanders LC, Sells MA, Wang HG, Reed JC, Bokoch GM: p21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis. Mol Cell Biol 20: 453–461, 2000
Widmann C, Gibson S, Johnson GL: Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J Biol Chem 273: 7141–7147, 1998
Lee N, MacDonald H, Reinhard C, Halenbeck R, Roulston A, Shi T, Williams LT: Activation of hPAK65 by caspase cleavage induces some of the morphological and biochemical changes of apoptosis. Proc Natl Acad Sci USA 94: 13642–13647, 1997
Jakobi R, Moertl E, Koeppel MA: p21-activated protein kinase gamma-PAK suppresses programd cell death of BALB3T3 fibroblasts. J Biol Chem 276: 16624–16634, 2001
Bagheri Y, Mandal M, Taludker AH, Wang RA, Vadlamudi RK, Kung HJ, Kumar R: Etk/Bmx tyrosine kinase activates Pak1 and regulates tumorigenicity of breast cancer cells. J Biol Chem 276: 29403–29409, 2001
Ellis LM, Fidler IJ: Angiogenesis and breast cancer metastasis. Lancet 346: 388–390, 1995
Fidler IJ: Modulation of the organ microenvironment for treatment of cancer metastasis. J Natl Cancer Inst 87: 1588–1592, 1995
Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353–364, 1996
Bagheri Y, Vadlamudi RK, Wang RA, Mendelsohn J, Kumar R: Vascular endothelial growth factor up-regulation via p21-activated kinase-1 signaling regulates heregulin-beta1-mediated angiogenesis. J Biol Chem 275: 39451–39457, 2000
Kiosses WB, Hood J, Yang S, Gerritsen ME, Cheresh DA, Alderson N, Schwartz MA: A dominant-negative p65 PAK peptide inhibits angiogenesis. Circ Res 90: 697–702, 2002
Sells MA, Knaus UG, Bagrodia S, Ambrose DM, Bokoch GM, Chernoff J: Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells. Curr Biol 7: 202–210, 1997
Adam L, Vadlamudi R, Mandal M, Chernoff J, Kumar R: Regulation of microfilament reorganization and invasiveness of breast cancer cells by kinase dead p21-activated kinase-1. J Biol Chem 275: 12041–12050, 2000
Sells MA, Pfaff A, Chernoff J: Temporal and spatial distribution of activated Pak1 in fibroblasts. J Cell Biol 151: 1449–1458, 2000
Dharmawardhane S, Brownson D, Lennartz M, Bokoch GM: Localization of p21-activated kinase 1 (PAK1) to pseudopodia, membrane ruffles, and phagocytic cups in activated human neutrophils. J Leukoc Biol 66: 521–527, 1999
Dharmawardhane S, Schurmann A, Sells MA, Chernoff J, Schmid SL, Bokoch GM: Regulation of macropinocytosis by p21-activated kinase-1. Mol Biol Cell 11: 3341–3352, 2000
Tao W, Pennica D, Xu L, Kalejta RF, Levine AJ: Wrch-1, a novel member of the Rho gene family that is regulated by Wnt-1. Genes Dev 15: 1796–1807, 2001
Xiao GH, Beeser A, Chernoff J, Testa JR: p21-activated kinase links Rac/Cdc42 signaling to merlin. J Biol Chem 277: 883–886, 2002
Zhang H, Li Z, Viklund EK, Stromblad S: p21-activated kinase 4 interacts with integrin alphavbeta5 and regulates alphavbeta5-mediated cell migration. J Cell Biol 158: 1287–1297, 2002
Faure S, Vigneron S, Doree M, Morin N: A member of the Ste20/PAK family of protein kinases is involved in both arrest of Xenopus oocytes at G2/prophase of the first meiotic cell cycle and in prevention of apoptosis. EMBO J 16: 5550–5561, 1997
Faure S, Vigneron S, Galas S, Brassac T, Delsert C, Morin N: Control of G2/M transition in Xenopus by a member of the p21-activated kinase (PAK) family: A link between protein kinase A and PAK signaling pathways? J Biol Chem 274: 3573–3579, 1999
Li F, Adam L, Vadlamudi RK, Zhou H, Sen S, Chernoff J, Mandal M, Kumar R: p21-activated kinase 1 interacts with and phosphorylates histone H3 in breast cancer cells. EMBO Rep 3: 767–773, 2002
Thiel D, Reeder M, Pfaff A, Coleman T, Sells M, Chernoff J: Cell Cycle-Regulated Phosphorylation of p21-Activated Kinase 1. Curr Biol 12: 1227, 2002
Banerjee M, Worth D, Prowse D, Nikolic M: Pak1 phosphorylation on t212 affects microtubules in cells undergoing mitosis. Curr Biol 12: 1233, 2002
Hofken T, Schiebel E: A role for cell polarity proteins in mitotic exit. EMBO J 21: 4851–4862, 2002
Mira JP, Benard V, Groffen J, Sanders LC, Knaus UG: Endogenous, hyperactive Rac3 controls proliferation of breast cancer cells by a p21-activated kinase-dependent pathway. Proc Natl Acad Sci USA 97: 185–189, 2000
Salh B, Marotta A, Wagey R, Sayed M, Pelech S: Dysregulation of phosphatidylinositol 3-kinase and downstream effectors in human breast cancer. Int J Cancer 98: 148–154, 2002
Renkema GH, Pulkkinen K, Saksela K: Cdc42/Rac1-mediated activation primes PAK2 for superactivation by tyrosine phosphorylation. Mol Cell Biol 22: 6719–6725, 2002
Roig J, Tuazon PT, Zipfel PA, Pendergast AM, Traugh JA: Functional interaction between c-Abl and the p21-activated protein kinase gamma-PAK. Proc Natl Acad Sci USA 97: 14346–14351, 2000
McManus MJ, Boerner JL, Danielsen AJ, Wang Z, Matsumura F, Maihle NJ: An oncogenic epidermal growth factor receptor signals via a p21-activated kinase-caldesmon-myosin phosphotyrosine complex. J Biol Chem 275: 35328–35334, 2000
Bekri S, Adelaide J, Merscher S, Grosgeorge J, Caroli B, Perucca L, Kelley PM, Pebusque MJ, Theillet C, Birnbaum D, Gaudray P: Detailed map of a region commonly amplified at 11q13→q14 in human breast carcinoma. Cytogenet Cell Genet 79: 125–131, 1997
Wang RA, Mazumdar A, Vadlamudi RK, Kumar R: P21-activated kinase-1 phosphorylates and transactivates estrogen receptor-alpha and promotes hyperplasia in mammary epithelium. EMBO J 21: 5437–5447, 2002
Yang F, Li X, Sharma M, Zarnegar M, Lim B, Sun Z: Androgen receptor specifically interacts with a novel p21-activated kinase, PAK6. J Biol Chem 276: 15345–15353, 2001
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vadlamudi, R.K., Kumar, R. p21-activated kinases in human cancer. Cancer Metastasis Rev 22, 385–393 (2003). https://doi.org/10.1023/A:1023729130497
Issue Date:
DOI: https://doi.org/10.1023/A:1023729130497